# Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)

> **NCT04676659** · PHASE2 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 240 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** TNK-tPA

## Key facts

- **NCT ID:** NCT04676659
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-12
- **Primary completion:** 2020-05-30
- **Final completion:** 2020-07-10
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2020-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04676659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04676659, "Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04676659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*